HCL Tech Q3's consolidated net profit stood at Rs 4,590 crore, compared to Rs 4,235 crore QoQ. Revenue increased to Rs 29,890 ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of ...

The Internet of Things (IoT) is a rapidly evolving field with the potential to reshape how we live, work, and interact with ...

US-listed peer Accenture Plc raising its revenue outlook last month showed greater deal flow from widespread ...

Overall, investors appear to view the incoming administration favorably for the sector, as the NSE Nifty IT Index has ...

Infosys, HCL Assess Business Outlook Under Trump - Shares of major Indian IT outsourcing firms , including Infosys Ltd., HCL Technologies Ltd., and Wipro ...

Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent ...

HCL Technologies Ltd (NS:HCLT), India’s third-largest IT services ... The Indian IT sector has faced slower growth amid ...

According to data from the US Citizenship and Immigration Services, as reported by news agency PTI, a total of 1.3 lakh H1B ...

Infosys led the Indian pack with 8,140 visas, followed by Tata Consultancy Services (TCS) with 5,274, and HCL America with ...

DSP-2342 is under clinical development by Sumitomo Pharma America and currently in Phase I for Unspecified Psychiatric Disorders.

The research notes the ongoing challenges of hiring local talent in the US and emphasises the indispensable role of H-1B ...